{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T04:27:50Z","timestamp":1769228870890,"version":"3.49.0"},"reference-count":14,"publisher":"Index Copernicus","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Otolaryngol Pol"],"published-print":{"date-parts":[[2020,2,20]]},"abstract":"<b>Background:<\/b> Mucormycosis is a rare fungal infection affecting people with impaired immunity. The aim of this study is to shed light on the epidemiology, incidence, and outcome of patients with mucormycosis hospitalized at a tertiary care center in Pondicherry. <br><b>Methods:<\/b> We conducted a retrospective chart review between January 2008 and January 2018. All patients with proven or probable mucormycosis were included. <br><b>Results:<\/b> A total of 24 patients were included. Their median age was 49 years and the majority were males. Comorbidities included mainly hematologic malignancy and diabetes mellitus. A liposomal amphotericin B formulation alone or in combination with other antifungals was used as a first line agent in all patients. <br><b>Conclusion:<\/b> The incidence of mucormycosis has significantly increased over the past 10 years at our institution, most likely due to increased risk factors.\n\n<\/jats:p>","DOI":"10.5604\/01.3001.0013.8593","type":"journal-article","created":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T13:48:32Z","timestamp":1582206512000},"page":"37-40","source":"Crossref","is-referenced-by-count":7,"title":["Nasal Mucormycosis:\nOur experience with 24 cases"],"prefix":"10.5604","volume":"74","author":[{"given":"Satvinder Singh","family":"Bakshi","sequence":"first","affiliation":[{"name":"All India Institute of Medical Sciences Mangalagiri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soumyajit","family":"Das","sequence":"additional","affiliation":[{"name":"All India Institute of Medical Sciences Mangalagiri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seepana","family":"Ramesh","sequence":"additional","affiliation":[{"name":"All India Institute of Medical Sciences Mangalagiri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suriyanarayanan","family":"Gopalakrishnan","sequence":"additional","affiliation":[{"name":"Mahatma Gandhi Medical College and Research Institutesri Balaji Vidyapeeth"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3689","reference":[{"key":"198534r1","unstructured":"Petrikkos G., Skiada A., Lortholary O., Roilides E., Walsh T.J. et al.: Epidemiologyand clinical manifestations of mucormycosis. Clin Infect Dis., 2016; 54: 23\u201334."},{"key":"198534r2","unstructured":"Jedrusik A., Galewicz A., Krzeski A., Dwilewicz-Trojaczek J., Depta\u0142a A. etal.: [Acute invasive fungal rhinosinusitis-case report]. Otolaryngol Pol., 2002;56(1): 95\u201399."},{"key":"198534r3","unstructured":"Cornely O.A., Arikan-Akdagli S., Dannaoui E., Groll A.H., Lagrou K. et al.:ESCMID and ECMM joint clinical guidelines for the diagnosis and managementof mucormycosis 2013. Clin Microbiol Infect., 2014; 20(Suppl 3): 5\u201326. 4 Szyfter W., \u0141aczkowska-Przybylska J.: [The diagnostic and therapeutical difficultiesof acute (fulminant) invasive mycotic rhinosinusitis]. OtolaryngolPol., 2008; 62(6): 710\u2013715."},{"key":"198534r4","unstructured":"Indian J Endocrinol Metab., 2014; 18(3): 379\u2013385."},{"key":"198534r5","unstructured":"De Pauw B., Walsh T.J., Donnelly J.P., Stevens D.A., Edwards J.E. et al.: RevisedDefinitions of Invasive Fungal Disease from the European Organization for Researchand Treatment of Cancer\/Invasive Fungal Infections Cooperative Groupand the National Institute of Allergy and Infectious Diseases Mycoses StudyGroup (EORTC\/MSG) Consensus Group. Clin Infect Dis., 2008; 46: 1813\u20131821."},{"key":"198534r6","unstructured":"Prakash H., Ghosh A.K., Rudramurthy S.M., Singh P., Xess I. et al.: A prospectivemulticenter study on mucormycosis in India: Epidemiology, diagnosis, andtreatment. Med Mycol., 2019; 57(4): 395\u2013402."},{"key":"198534r7","doi-asserted-by":"crossref","unstructured":"Chakrabarti A., Singh R.: Mucormycosis in India: unique features; Mycoses.2014; 57 (Suppl 3): 85\u201390.","DOI":"10.1111\/myc.12243"},{"key":"198534r8","unstructured":"Skiada A., Lanternier F., Groll A.H., Pagano L., Zimmerli S. et al.: Diagnosisand treatment of mucormycosis in patients with hematological malignancies:guidelines from the 3rd European Conference on Infections in Leukemia (ECIL3). Haematologica., 2013; 98: 492\u2013504."},{"key":"198534r9","unstructured":"Deepa M., Bhansali A., Anjana R.M. et al.: Knowledge and awareness of diabetesin urban and rural India: The Indian Council of Medical Research IndiaDiabetes Study (Phase I): Indian Council of Medical Research India Diabetes"},{"key":"198534r10","unstructured":"Vaughan C., Bartolo A., Vallabh N., Leong S.C.: A meta-analysis of survivalfactors in rhino-orbital-cerebral mucormycosis-has anything changed in thepast 20 years? Clin Otolaryngol., 2018; 43(6): 1454\u20131464."},{"key":"198534r11","unstructured":"Palejwala S.K., Zangeneh T.T., Goldstein S.A., Lemole G.M.: An aggressivemultidisciplinary approach reduces mortality in rhinocerebral mucormycosis.Surg Neurol Int., 2016; 7: 61."},{"key":"198534r12","unstructured":"Riley T.T., Muzny C.A., Swiatlo E., Legendre D.P.; Breaking the Mold: A Reviewof Mucormycosis and Current Pharmacological Treatment Options. AnnPharmacother., 2016; 50(9): 747\u2013757."},{"key":"198534r13","doi-asserted-by":"crossref","unstructured":"Pilmis B., Alanio A., Lortholary O., Lanternier F.: Recent advances in the understandingand management of mucormycosis. F1000Res., 2018; 7. pii: F1000Faculty Rev-1429. DOI: 10.12688\/f1000research.15081.1.","DOI":"10.12688\/f1000research.15081.1"},{"key":"198534r14","doi-asserted-by":"crossref","unstructured":"Skiada A., Lass-Floerl C., Klimko N., Ibrahim A., Roilides E. et al.: Challenges in thediagnosis and treatment of mucormycosis. Med Mycol., 2018; 56(suppl_1): 93\u2013101.","DOI":"10.1093\/mmy\/myx101"}],"container-title":["Otolaryngologia Polska"],"original-title":[],"link":[{"URL":"https:\/\/otolaryngologypl.com\/gicid\/pdf\/01.3001.0013.8593","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/otolaryngologypl.com\/gicid\/pdf\/01.3001.0013.8593","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T13:59:01Z","timestamp":1598018341000},"score":1,"resource":{"primary":{"URL":"https:\/\/otolaryngologypl.com\/gicid\/01.3001.0013.8593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,20]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,3,25]]}},"URL":"https:\/\/doi.org\/10.5604\/01.3001.0013.8593","relation":{},"ISSN":["0030-6657","2300-8423"],"issn-type":[{"value":"0030-6657","type":"print"},{"value":"2300-8423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,20]]}}}